Editorial mail

Editorial correspondence

The address is editors@agilitypeptide.com.

Sources that overturn an interpretation are welcome, alongside corrections to an experimental model or an identifier pointing to the wrong publication. Please include the page, the passage and the DOI or PubMed identifier where possible. A proposed correction can then be checked against the actual paper.

New work on cell movement, blood-vessel growth, matrix remodeling or the KLOW mixture is relevant, especially when an experiment challenges a familiar claim. The references show the publications currently discussed. The mailbox is checked intermittently, so a reply may take time and is not guaranteed.

Requests about treatment

A factual dispute about a passage here belongs in this mailbox. An editorial mailbox cannot assess an injury, diagnose a condition, arrange a prescription or advise on a dose, route or schedule. The address is for editorial matters. Individual medical questions need a licensed clinician with access to the person’s circumstances.

Supply requests and product recommendations also sit beyond this notebook. For the scope and the reason it exists, see about Agility Peptide.